Molecular analysis of primary and metastatic sites in patients with renal cell carcinoma is a research paper published in Journal of Clinical Investigation (2024). On theSindex it has a DataRank of 0. It has been cited 31 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: K08CA273542
NCI NIH HHS
Grant: T32 CA009172
NCI NIH HHS
Grant: P50 CA196516
National Institutes of Health
Grant: 5P50CA196516-05
The University of Texas Southwestern Medical Center SPORE in Kidney Cancer
National Institutes of Health
Grant: 5K08CA273542-04
Combination of Transcriptomic and Metallomic Biomarkers for Risk Assessment in Locoregional Clear Cell Renal Cell Carcinoma
FWCI
9.05
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals